Intensive and Critical Care Nursing
Volume 24, Issue 5 , Pages 286-294 , October 2008

A description of the characteristics of patients with non-ST elevation acute coronary syndromes admitted to different settings in the 1990s

  • Ian Jones

      Affiliations

    • Salford Centre for Nursing Midwifery and Collaborative Research, Mary Seacole Building, Frederick Road Campus, University of Salford, Salford, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 161 295 7278.
    • ,
  • Marcus Flather

      Affiliations

    • Clinical Trials Evaluation Unit, Royal Brompton Hospital, Sydney Street, London, UK
    • Tel.: +44 207 352 8121.
    • ,
  • Martin Johnson

      Affiliations

    • Salford Centre for Nursing Midwifery and Collaborative Research, Allerton Building, Frederick Road Campus, University of Salford, Salford, UK
    • Tel.: +44 161 295 5000.
    • ,
  • Steve Barrow

      Affiliations

    • Allerton Building, Frederick Road Campus, University of Salford, Salford, UK
    • Tel.: +44 161 295 5000.
    • ,
  • D. Thompson

      Affiliations

    • Department of Health Sciences & Cardiovascular Sciences, University of Leicester, UK

,Accepted 29 January 2008.

References 

  1. Adlerberth AM, Rosengren A, Wilhelmsen L. Diabetes and long term risk of mortality from coronary and other causes in middle aged Swedish men. A general population study. Diabetes Care. 2001;21(4):539–545
  2. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, et al. Cardiac specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. New Engl J Med. 1996;335:1342–1349
  3. Antman EM, Cohen M, Bernink P, McCabe C, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/non-ST elevation MI. A method for prognostication and therapeutic decision making. J Am Med Assoc. 2000;284:835–842
  4. Bakhai A, Collinson J, Flather MD, Perez de Arenaza D, Shibata MC, Wang D, et al. Diabetic patients with acute coronary syndromes in the UK: high risk and under treated. Results from the prospective registry of acute ischaemic events syndromes in the UK (PRAIS-UK). Int J Cardiol. 2005;100:79–84
  5. Boersma E, Pieper KS, Steyerberg EW. Predictors of outcome in patients with acute coronary syndromes without persistent ST segment elevation results from an international trial of 9461 patients. Circulation. 2000;101:2557–2560
  6. Braunwald EB. Evolution of the management of acute myocardial infarction: a 20th Century saga. Lancet. 1998;352:1771–1774
  7. Calvin J, Klein LW, VandenBerg BJ, Meyer P, Condon JV, Snell RJ, et al. Risk stratification in unstable angina. Prospective validation of the Braunwald classification. J Am Med Assoc. 1995;273:136–141
  8. Cannon CP, McCabe CH, Stone PH, Rogers WJ, Schactman M, Thompson BW, et al. The electrocardiogram predicts one-year mortality of patients with unstable angina and non Q wave myocardial infarction: results of the TIMI registry ECG ancillary study. J Am Coll Cardiol. 1997;30(1):133–140
  9. Collinson J, Flather M, Fox KAAA, Findlay I, Rodrigues E, Dooley P, et al. Clinical outcomes, risk stratification and practice patterns of unstable angina and myocardial infarction without ST elevation: prospective registry of acute ischaemic syndromes in the UK (PRAIS-UK). Eur Heart J. 2000;21:1450–1457
  10. Collinson J, Perez de Arenaza D, Flather MD, Bakhai A, Adgey J, Fox KAA. Managing high risk patients with acute coronary syndromes: the prospective registry of acute ischaemic events syndromes in the UK (PRAIS-UK). Clin Med. 2004;4(4):369–375
  11. Dudley NJ, Burns E. The influence of age on policies for admission and thrombolysis in coronary care units in the United Kingdom. Age Ageing. 1992;21(2):95
  12. Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Van de Werf F, et al. A validated prediction model for all forms of acute coronary syndrome. Estimating the risk of 6 month post discharge death in an international registry. J Am Med Assoc. 2004;291(22):2727–2733
  13. Global Use of Strategies To Open Occluded Coronary Arteries (GUSTO) IIB Investigators. A comparison of recombinant Hirudin with heparin for the treatment of acute coronary syndromes. New Engl J Med 1996;335:775–82.
  14. Granger CB, Goldberg RJ, Dabbous O. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003;176:2345–2353
  15. Herlitz J, Malmberg K, Karlsson BW, Ryden L, Hjalmarson A. Mortality and morbidity during a five year follow-up of diabetics with myocardial infarction. Acta Med Scand. 1988;224:31–38
  16. Herlitz J, Karlson BW, Karlsson T, Svensson L, Zehlertz E, Kalin B. A Description of the characteristics and outcome of patients hospitalised for acute chest pain in relation to whether they were admitted to the coronary care unit or not in the thrombolysis era. Int J Cardiol. 2002;82:279–287
  17. Holmvang L, et al. Very early risk stratification using combined ECG and biochemical markers in patients with unstable coronary artery disease (a thrombin inhibition in myocardial ischeamia [TRIM] sub study). Circulation. 1998;98:2004–2009
  18. Jackson G. Coronary artery disease and women. Br Med J. 1994;309:555–557
  19. Killip T, Kimball JT. Treatment of a myocardial infarction in a coronary care unit. A two-year experience with 250 patients. Am J Cardiol. 1967;20:457–464
  20. Kleiman NS, White HD. The declining prevalence of ST elevation myocardial infarction in patients presenting with acute coronary syndromes. Heart. 2005;91:1121–1123
  21. Klein L, Gheorgehiade M. Management of the patient with diabetes mellitus and myocardial infarction: clinical trials update. Am J Med. 2004;116(Suppl 5A):47S–63S
  22. Malmberg K, Norhammar A, Wedel H, Ryden L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction. Long term results from the diabetes and insulin–glucose in acute myocardial infarction study. Circulation. 1997;99:2626–2632
  23. Maynard SJ, Scott J, Riddell W, Adgey AAJ. Management of acute coronary syndromes. Br Med J. 2000;321:220–223
  24. McSweeney JC, Lefler LL, Crowder BF. What's wrong with me? Women's coronary heart disease diagnostic experiences. Prog Cardiovasc Nurs. 2005;20(2):48–57
  25. Quinn T, Weston C, Birkhead J, Walker L, Norris R. Redefining the coronary care unit: an observational study of patients admitted to hospital in England and Wales in 2003. Q J Med. 2005;98:797–802
  26. Sacks FM, et al. Efficacy of Pravastain on coronary events after myocardial infarction in patients with average cholesterol levels. Five year follow up of patients with starting cholesterol <6.2mmol/l treated with Pravastatin. New Engl J Med. 1996;335:1001–1009
  27. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease (4S). Lancet. 1994;344:1383–1389
  28. Stamler J, Vaccoro O, Neaton JD, Wentworth D. Diabetes, other risk factors and 12 year cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care. 1993;16(2):434–444
  29. Wood D, Durrington P, McInnes G, Poulter N, Rees A, Wray R. Joint British recommendations of the prevention of coronary heart disease in clinical practice. Heart. 1998;80:S1–S29

PII: S0964-3397(08)00009-8

doi: 10.1016/j.iccn.2008.01.005

Intensive and Critical Care Nursing
Volume 24, Issue 5 , Pages 286-294 , October 2008

Article Tools

* Image Usage & Resolution